Prolactin is found to be a potential treatment for inflammatory joint disease, finds study published in Journal of Clinical Investigation.
Inflammatory joint diseases such as rheumatoid arthritis are the result of cartilage damage and loss. Chondrocytes are the only cells that are found in cartilage and their death is linked to decreased cartilage health.
AdvertisementProlactin treatment prevented chondrocyte death and associated cartilage degradation. In a rat model of inflammatory arthritis, prolactin treatment reduced inflammation, bone erosion, joint swelling, and pain. This study indicates that prolactin therapy has the potential to relieve many symptoms associated with rheumatoid arthritis and other inflammatory-related diseases.
P New Drug Targets to Help Fight Alzheimer's Disease Identified People's Names can Reveal Lot About Their Lives: Study M
You May Also Like